{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T01:51:33Z","timestamp":1726278693693},"publisher-location":"Berlin, Heidelberg","reference-count":38,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642732829"},{"type":"electronic","value":"9783642732805"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1988]]},"DOI":"10.1007\/978-3-642-73280-5_2","type":"book-chapter","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T19:34:26Z","timestamp":1343504066000},"page":"12-26","source":"Crossref","is-referenced-by-count":4,"title":["Receptor Interactions of Dopamine and Serotonin Antagonists: Binding In Vitro and In Vivo and Receptor Regulation"],"prefix":"10.1007","author":[{"given":"J. E.","family":"Leysen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Gommeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. F. M.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gompel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A. J.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF00497017","volume":"324","author":"MA Blackshear","year":"1983","unstructured":"Blackshear MA, Friedman RL, Sanders-Bush E (1983) Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites. Naunyn Schmiedebergs Arch Pharmacol 324: 125\u2013129","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF00431801","volume":"87","author":"A Campbell","year":"1985","unstructured":"Campbell A, Baldessarini RJ, Teicher MH, Kula NS (1985) Prolonged antidopaminergic actions of single doses of butyrophenones in the rat. Psychopharmacology 87: 161\u2013166","journal-title":"Psychopharmacology"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF00428197","volume":"85","author":"DLS Ceulemans","year":"1985","unstructured":"Ceulemans DLS, Gelders YG, Hoppenbrouwers M-LJA, Reyntjens ASM, Janssen PAJ (1985) Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone. Psychopharmacology 85: 329\u2013339","journal-title":"Psychopharmacology"},{"key":"2_CR4","first-page":"89","volume":"24","author":"I Creese","year":"1980","unstructured":"Creese I, Snyder SH (1980) Chronic neuroleptic treatment and dopamine receptor regulation. Adv Biochem Psychopharmacol 24: 89\u201394","journal-title":"Adv Biochem Psychopharmacol"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1126\/science.877576","volume":"197","author":"I Creese","year":"1977","unstructured":"Creese I, Burt DR, Snyder SH (1977) Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science 197: 596\u2013598","journal-title":"Science"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/ddr.430080120","volume":"8","author":"D Chaffoy de Courcelles De","year":"1986","unstructured":"De Chaffoy de Courcelles D, Leysen JE, Roevens P, van Belle H (1986) The serotonin-S2 receptor: a receptor-transducer coupling model to explain insurmountable antagonist effects: Drug Dev Res 8: 173\u2013178","journal-title":"Drug Dev Res"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/0006-2952(83)90397-0","volume":"32","author":"S Fleminger","year":"1983","unstructured":"Fleminger S, Rupniak NMJ, Hall MD, Jenner P, Marsden CD (1983) Changes in apomorphine- induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increase in D-l receptors. Biochem Pharmacol 32: 2921\u20132927","journal-title":"Biochem Pharmacol"},{"key":"2_CR8","first-page":"782","volume":"229","author":"O Gandolfi","year":"1984","unstructured":"Gandolfi O, Barbaccia ML, Costa E (1984) Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors. J Pharmacol Exp Ther 229: 782\u2013786","journal-title":"J Pharmacol Exp Ther"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/0024-3205(85)90190-0","volume":"36","author":"O Gandolfi","year":"1985","unstructured":"Gandolfi O, Barbaccia ML, Costa E (1985) Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites. Life Sci 36: 713\u2013721","journal-title":"Life Sci"},{"issue":"4","key":"2_CR10","first-page":"325","volume":"9","author":"Y Gelders","year":"1986","unstructured":"Gelders Y, Vanden Bussche G, Reyntjens A, Janssen P (1986) Serotonin-S2 receptor blockers in the treatment of chronic schizophrenia. Clin Neuropharmacol [Suppl 4] 9: 325\u2013327","journal-title":"Clin Neuropharmacol"},{"key":"2_CR11","first-page":"19","volume":"78","author":"HJ Haase","year":"1978","unstructured":"Haase HJ (1978) The purely neuroleptic effects and its relation to the \u201cneuroleptic threshold\u201d. Acta Psychiatr Belg 78:19\u201336","journal-title":"Acta Psychiatr Belg"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF01249875","volume":"59","author":"H Hall","year":"1984","unstructured":"Hall H, Ross SB, Sallemark M (1984) Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressants on \u03b2-adrenoceptors and 5-HT2 binding sites in the rat cerebral cortex. J Neural Transm 59: 9\u201323","journal-title":"J Neural Transm"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/BF00427416","volume":"83","author":"J Hyttel","year":"1984","unstructured":"Hyttel J, Fredericson Overo K, Arnt J (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 83: 20\u201327","journal-title":"Psychopharmacology"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1113\/jphysiol.1957.sp005838","volume":"138","author":"B Katz","year":"1957","unstructured":"Katz B, Thesleff S (1957) A study of the \u201cdesensitization\u201d produced by acetylcholine at the motor end plate. J Physiol (Lond) 138: 63\u201380","journal-title":"J Physiol (Lond)"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0006-2952(78)90234-4","volume":"27","author":"PM Laduron","year":"1978","unstructured":"Laduron PM, Janssen PFM, Leysen JE (1978) Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs. Biochem Pharmacol 27: 317\u2013321","journal-title":"Biochem Pharmacol"},{"key":"2_CR16","first-page":"315","volume-title":"Advances in human psychopharmacology","author":"JE Leysen","year":"1984","unstructured":"Leysen JE (1984) Receptors for neuroleptic drugs. In: Burrows GD, Werry JS (eds) Advances in human psychopharmacology 3. Jai, London, pp 315\u2013356"},{"key":"2_CR17","unstructured":"Leysen JE (1987) The use of 5-HT receptor agonists and antagonists for the characterization of their respective receptor sites. In: Boulton AA, Blake GB, Juorio AV (eds) Drugs as tools in neurotransmitter research. Humana, Clifton (Neuromethods, neuropharmacology, vol 2) (in press)"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/10799898409041867","volume":"4","author":"JE Leysen","year":"1984","unstructured":"Leysen JE, Gommeren W (1984) The dissociation rate of unlabelled dopamine antagonists and agonists from the dopamine-D2 receptor, application of an original filter method. J Recept Res 4: 817\u2013845","journal-title":"J Recept Res"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ddr.430080115","volume":"8","author":"JE Leysen","year":"1986","unstructured":"Leysen JE, Gommeren W (1986) Drug-receptor dissociation time, new tool for drug research: receptor binding affinity and drug-receptor dissociation profiles of serotonin-S2, dopamine- D2, histamine-H1 antagonists, and opiates. Drug Dev Res 8: 119\u2013131","journal-title":"Drug Dev Res"},{"key":"2_CR20","unstructured":"Leysen JE, Janssen PAJ (1987) Specificity of ligands used in psychiatric research. In: Sen AK, Lee T (eds) Receptors and ligands in psychiatry and neurology, vol 1. Cambridge University Press, Cambridge (in press)"},{"key":"2_CR21","first-page":"331","volume-title":"Handbook of neurochemistry","author":"JE Leysen","year":"1985","unstructured":"Leysen JE, Niemegeers CJE (1985) Neuroleptics. In: Lajtha A (ed) Handbook of neurochemistry. Plenum, New York, pp 331\u2013361"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/272168a0","volume":"272","author":"JE Leysen","year":"1978","unstructured":"Leysen JE, Niemegeers CJE, Tollenaere JP, Laduron PM (1978) Serotonergic component of neuroleptic receptors. Nature 272: 168\u2013171","journal-title":"Nature"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/0024-3205(81)90747-5","volume":"28","author":"JE Leysen","year":"1981","unstructured":"Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci 28: 1015\u20131022","journal-title":"Life Sci"},{"key":"2_CR24","first-page":"373","volume-title":"CNS receptors\u2013From molecular pharmacology to behavior","author":"JE Leysen","year":"1983","unstructured":"Leysen JE, Van Gompel P, Verwimp M, Niemegeers CJE (1983) Role and localization of serotonin2 (S2)-receptor-binding sites: effects of neuronal lesions. In: Mandel P, DeFeudis FV (eds) CNS receptors\u2013From molecular pharmacology to behavior. Raven, New York, pp 373\u2013383"},{"key":"2_CR25","first-page":"600","volume":"27","author":"JE Leysen","year":"1985","unstructured":"Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PFM, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin. A very potent and long-acting serotonin-S2 antagonist. Mol Pharmacol 27: 600\u2013611","journal-title":"Mol Pharmacol"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/BF00178504","volume":"88","author":"JE Leysen","year":"1986","unstructured":"Leysen JE, Van Gompel P, Gommeren W, Woestenborghs R, Janssen PAJ (1986) Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone. Psychopharmacology 88: 434\u2013444","journal-title":"Psychopharmacology"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/978-3-642-71288-3_25","volume-title":"Clinical pharmacology in psychiatry","author":"JE Leysen","year":"1987","unstructured":"Leysen JE, Van Gompel P, Gommeren W, Laduron PM (1987) Differential regulation of dopamine-D2 and serotonin-S2 receptors by chronic treatment with the serotonin-S2 antagonists, ritanserin, and setoperone. In: Dahl SG, Gram LF, Paul SM, Potter WZ (eds) Clinical pharmacology in psychiatry. Springer, Berlin Heidelberg New York, pp 214\u2013224 (Psychopharmacology series, vol 3 )"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1176\/ajp.141.3.412","volume":"141","author":"JF Lipinski","year":"1984","unstructured":"Lipinski JF, Zubenko GS, Cohen BM, Barreira PJ (1984) Propranolol in the treatment of neuro-leptic induced akathisia. Am J Psychiatry 141: 412\u2013415","journal-title":"Am J Psychiatry"},{"key":"2_CR29","first-page":"582","volume":"215","author":"SJ Peroutka","year":"1980","unstructured":"Peroutka SJ, Snyder SH (1980) Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline. J Pharmacol Exp Ther 215: 582\u2013587","journal-title":"J Pharmacol Exp Ther"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/ddr.430080124","volume":"8","author":"A Reyntjens","year":"1986","unstructured":"Reyntjens A, Gelder YG, Hoppenbrouwers M-LJA, Vanden Bussche G (1986) Thymosthenic effects of ritanserin (R 55 667), a centrally acting serotonin-S2 receptor blocker. Drug Dev Res 8: 205\u2013211","journal-title":"Drug Dev Res"},{"key":"2_CR31","first-page":"229","volume":"32","author":"P Seeman","year":"1980","unstructured":"Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32: 229\u2013313","journal-title":"Pharmacol Rev"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-0186(87)90167-7","volume":"10","author":"P Seeman","year":"1987","unstructured":"Seeman P, Grigoriadis D (1987) Dopamine receptors in brain and periphery. Neurochem Int 10: 1\u201325","journal-title":"Neurochem Int"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-2007-1019525","volume":"15","author":"SH Snyder","year":"1982","unstructured":"Snyder SH, Peroutka SJ (1982) A possible role of serotonin receptors in antidepressant drug action. Pharmacopsychiatry 15: 131\u2013134","journal-title":"Pharmacopsychiatry"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0197-0186(87)90168-9","volume":"10","author":"PG Strange","year":"1987","unstructured":"Strange PG (1987) Dopamine receptors in the brain and periphery: \u201cstate of the art\u201d. Neurochem Int 10: 27\u201333","journal-title":"Neurochem Int"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/0028-3908(74)90084-7","volume":"13","author":"D Tarsy","year":"1974","unstructured":"Tarsy D, Baldessarini RJ (1974) Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology 13: 927\u2013940","journal-title":"Neuropharmacology"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","volume":"82","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system in the rat brain. Acta Physiol Scand [Suppl 367] 82: 69\u201393","journal-title":"Acta Physiol Scand [Suppl 367]"},{"key":"2_CR37","first-page":"1984","volume":"8","author":"PS Wielink Van","year":"1983","unstructured":"Van Wielink PS, Leysen JE (1983) Farmacologische keuzecriteria voor neuroleptica. Tijdschr Geneesmiddelenonderz 8: 1984\u20131997","journal-title":"Tijdschr Geneesmiddelenonderz"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF00499215","volume":"239","author":"J Vetulani","year":"1976","unstructured":"Vetulani J, Starwarz RJ, Dingell JV, Sulser F (1976) A possible common mechanism of action of antidepressant treatments. Arch Pharmacol 239:109114","journal-title":"Arch Pharmacol"}],"container-title":["Psychopharmacology: Current Trends"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-73280-5_2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T21:04:30Z","timestamp":1606251870000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-73280-5_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988]]},"ISBN":["9783642732829","9783642732805"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-73280-5_2","relation":{},"subject":[],"published":{"date-parts":[[1988]]}}}